Insiders who have reported open-market trades at the same companies as John K. Bakewell. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
John K. Bakewell is a corporate insider, tracked as Director of Xtant Medical Holdings, Inc. (XTNT). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John K. Bakewell submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
John K. Bakewell is Director of Xtant Medical Holdings, Inc. (XTNT). 4 SEC Form 4 filings on record going back to 2025, most recently on 18 August 2026.
Recent transactions
4
The latest 4 SEC Form 4 transactions reported by John K. Bakewell.
InsiderAlpha's records for John K. Bakewell go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
